External broker reports(aggregated public sources), RHB Invest

RHB Invest

External broker reports(aggregated public sources)

RHB Investment Bank is one of the leading capital market players in Malaysia. Supported by an award-winning research team of experienced product specialists, RHB Group Investment Banking offers a full range of investment banking products and services covering primary markets, such as advisory (corporate & debt restructuring, mergers and acquisitions, takeovers), fundraising via both equity and debt instruments, and secondary markets including securities trading for both institutional and retail clients. 

Content available is external broker reports authored by a third party outside the Smartkarma network and has been aggregated by an online aggregator through publicly available sources and is displayed by Smartkarma in this format for user's convenience and general informational purposes only. Content does not constitute investment or financial advice and Smartkarma makes no representation or warranty regarding its accuracy or contents. Original third party author retains all copyright and other proprietary rights in the content. Access or use of third party links not controlled by Smartkarma are at the user's own risk.

Equity Bottom-Up

<ul><li>We remain upbeat on Centurion Corp (SGX:OU8), as 1Q23’s revenue growth validates improving demand for its assets globally.</li><li>Occupancy continues to improve in all Centurion’s key markets and it remains on track to meet our forecasts.</li><li>We expect growth to be driven by both increased bed capacities and better rental rates.</li></ul>Content is external broker report sourced from online content aggregator through publicly available sources and is displayed below for general informational purposes only. Refer full disclaimer below.

We remain upbeat on Centurion Corp (SGX:OU8), as 1Q23’s revenue growth validates improving demand for its assets globally.Occupancy continues to improve in all Centurion’s key markets and it remains on track to meet our forecasts.We expect growth to be driven by both increased bed capacities and better rental rates.Content is external broker report sourced from online content aggregator through publicly available sources and is displayed below for general informational purposes only. Refer full disclaimer below.

Centurion Corp - Higher Capacities, AEI Driving Growth; Keep BUY

External broker reports(aggregated public sources), UOB Kay Hian

UOB Kay Hian

Backed by the UOB Group, UOB Kay Hian is one of Asia’s largest brokerage firms. Headquartered in Singapore, we are supported by more than 80 branches worldwide including a growing network of offices across Southeast Asia, Greater China, the United Kingdom and North America. Our global footprint and strong international presence have enabled us to feel the pulse of key financial markets and deliver incisive intelligence across industry sectors and asset classes. Content available is external broker reports authored by a third party outside the Smartkarma network and has been aggregated by an online aggregator through publicly available sources and is displayed by Smartkarma in this format for user's convenience and general informational purposes only. Content does not constitute investment or financial advice and Smartkarma makes no representation or warranty regarding its accuracy or contents. Original third party author retains all copyright and other proprietary rights in the content. Access or use of third party links not controlled by Smartkarma are at the user's own risk.

<ul><li>Centurion’s 1Q23 business update was a solid one with revenue up 5% y-o-y to S$47m making up 25% of our full-year forecast and thus in line with expectation.</li><li>The key PBWA segment, which makes up three-quarters of its revenue, saw 5% y-o-y growth in its top-line while its PBSA segment was similarly robust, up 7% y-o-y.</li><li>In addition, Centurion stated that rental reversions were healthy and with its ability to pass on inflation and higher costs, it would appear that profit margins have easily been maintained, in our view.</li></ul>Content is external broker report sourced from online content aggregator through publicly available sources and is displayed below for general informational purposes only. Refer full disclaimer below.

Centurion’s 1Q23 business update was a solid one with revenue up 5% y-o-y to S$47m making up 25% of our full-year forecast and thus in line with expectation.The key PBWA segment, which makes up three-quarters of its revenue, saw 5% y-o-y growth in its top-line while its PBSA segment was similarly robust, up 7% y-o-y.In addition, Centurion stated that rental reversions were healthy and with its ability to pass on inflation and higher costs, it would appear that profit margins have easily been maintained, in our view.Content is external broker report sourced from online content aggregator through publicly available sources and is displayed below for general informational purposes only. Refer full disclaimer below.

Centurion Corp - Continuing On Its Recovery Across All Asset Classes

SGX Market Strategist, Equity & Fixed Income, Singapore Exchange Ltd (SGX)

Geoff Howie

SGX Market Strategist, Equity & Fixed Income

Asia’s leading multi-asset exchange

Singapore Exchange Ltd (SGX)

Singapore Exchange is Asia’s leading and trusted market infrastructure, facilitating the exchange of capital and ideas to create value for people, businesses and economies. As a multi-asset exchange operating equity, fixed income and derivatives markets to the highest regulatory standards, SGX is a vertically integrated business that provides listing, trading, clearing, settlement, depository and data services.

With about 40% of listed companies and over 80% of listed bonds originating outside of Singapore as well as established linkages across the region and in Europe, SGX is Asia’s most international and connected exchange. Offering a full suite of derivatives products across Asian equity indices, commodities and currencies, SGX is the world’s most liquid international market for the benchmark equity indices of China, India, Japan and ASEAN.

As Asia’s pioneering central counterparty, SGX is globally recognised for its risk management and clearing capabilities, and was one of the first globally to adopt the Principles for Financial Market Infrastructure.

Headquartered in AAA-rated Singapore, SGX has over 800 employees including offices in Beijing, Chicago, Hong Kong, London, New York, Mumbai, San Francisco, Shanghai and Tokyo.

10 in 10 with Centurion Corporation - Specialised Accomodations with a Heart 

Pan-Asia Catalysts/Events, Quiddity Advisors

David Blennerhassett

Pan-Asia Catalysts/Events

Quiddity Advisors

Event-Driven

<ul>
<li>The data in this insight is collated from the "shareholding disclosure" link on the HKEx website.</li>
<li>Often there is a corresponding HKEx announcement on the increase - or decrease - in the shareholding by directors. However, such disclosures are by no means an absolute. </li>
<li>These insights may flag those companies where shares have been pledged. Stocks mentioned include <a href="https://www.smartkarma.com/entities/c-c-land-holdings-ltd" target="_blank" data-smartkarma-citation="entities:13078:1" rel="noopener">C C Land Holdings (1224 HK)</a>, <a href="https://www.smartkarma.com/entities/impro-precision-industries" target="_blank" data-smartkarma-citation="entities:26779:1" rel="noopener">Impro Precision Industries (1286 HK)</a>, and <a href="https://www.smartkarma.com/entities/singasia-holdings-ltd" target="_blank" data-smartkarma-citation="entities:27986:1" rel="noopener">SingAsia Holdings (8293 HK)</a>.</li>
</ul>


The data in this insight is collated from the "shareholding disclosure" link on the HKEx website.
Often there is a corresponding HKEx announcement on the increase - or decrease - in the shareholding by directors. However, such disclosures are by no means an absolute. 
These insights may flag those companies where shares have been pledged. Stocks mentioned include C C Land Holdings (1224 HK), Impro Precision Industries (1286 HK), and SingAsia Holdings (8293 HK).


Hong Kong CEO & Director Dealings (11 Nov): C C Land, Impro Precision, SingAsia, Pharmaron

<ul>
<li>The data in this insight is collated from the "shareholding disclosure" link on the HKEx website. </li>
<li>Often there is a corresponding HKEx announcement on the increase - or decrease - in the shareholding by directors. However, such disclosures are by no means an absolute. </li>
<li>These insights may also flag those companies where shares have been pledged. Stocks mentioned include <a href="https://www.smartkarma.com/entities/pharmaron-beijing-co-ltd" target="_blank" data-smartkarma-citation="entities:28428:1" rel="noopener">Pharmaron Beijing (3759 HK)</a>, <a href="https://www.smartkarma.com/entities/joinn-laboratories-china-c-h" target="_blank" data-smartkarma-citation="entities:31498:1" rel="noopener">Joinn Laboratories (H) (6127 HK)</a>, and <a href="https://www.smartkarma.com/entities/glory-sun-financial-group-ltd" target="_blank" data-smartkarma-citation="entities:17758:1" rel="noopener">Glory Sun Financial Group (1282 HK)</a>.</li>
</ul>


The data in this insight is collated from the "shareholding disclosure" link on the HKEx website. 
Often there is a corresponding HKEx announcement on the increase - or decrease - in the shareholding by directors. However, such disclosures are by no means an absolute. 
These insights may also flag those companies where shares have been pledged. Stocks mentioned include Pharmaron Beijing (3759 HK), Joinn Laboratories (H) (6127 HK), and Glory Sun Financial Group (1282 HK).


Hong Kong CEO & Director Dealings: 22nd Sept - Pharmaron Beijing, Joinn Labs, Glory Sun Financial

Singapore

Centurion Corporation Limited owns, develops and manages quality, purpose-built workers accommodation assets in Singapore and Malaysia, and purpose-built student accommodation assets in Singapore, Australia, the United Kingdom (“UK”), the United States (“US”) and South Korea.

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00

Centurion Corp (CENT SP)

Centurion Corp - Higher Capacities, AEI Driving Growth; Keep BUY

We remain upbeat on Centurion Corp (SGX:OU8), as 1Q23’s revenue growth validates improving demand for its assets globally.

RHB Invest

Centurion Corp - Continuing On Its Recovery Across All Asset Classes

Centurion’s 1Q23 business update was a solid one with revenue up 5% y-o-y to S$47m making up 25% of our full-year forecast and thus in line with...

UOB Kay Hian

10 in 10 with Centurion Corporation - Specialised Accomodations with a Heart

10 in 10 with Centurion Corporation - Specialised Accomodations with a Heart

Singapore Exchange Ltd (SGX)

Hong Kong CEO & Director Dealings (11 Nov): C C Land, Impro Precision, SingAsia, Pharmaron

The data in this insight is collated from the "shareholding disclosure" link on the HKEx website. These insights also flag those companies where...

David Blennerhassett

Hong Kong CEO & Director Dealings: 22nd Sept - Pharmaron Beijing, Joinn Labs, Glory Sun Financial

The data in this insight is collated from the "shareholding disclosure" link on the HKEx website. These insights also flag those companies where...

David Blennerhassett

Price Gauge

52-week Range

Market Cap (USDm)

P/E

Dividend (Yield)